Dr. Wu Appointed to the Staging and Prognostic Factors Group of the International Association for the Study of Lung Cancer
In the latest committee election held by the International Association for the Study of Lung Cancer (IASLC), Professor Wu Fang from our hospital has been appointed as a member of the Staging and Prognostic Factors Group (SPFG). This appointment recognizes her significant contributions to lung cancer staging and treatment. As part of her new role, […]